RayzeBio, a subsidiary of Bristol Myers Squibb, aims to develop transformative radiopharmaceutical therapies for cancer patients.
Base: $261,110 - $316,404; Bonus/Equity: Additional incentive cash and stock opportunities; Benefits: Health Coverage, Wellbeing Support, Financial Well-being, Work-life benefits
Must-have
Nice-to-have
Not specified